<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone marrow samples from 30 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) grouped according to the International Prognostic Scoring System for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were investigated for counts of microvessels, total metachromatic mast cells (MC) and MC expressing tryptase, an <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>-inducing molecule </plain></SENT>
<SENT sid="1" pm="."><plain>Counts were higher in patients with a poor prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>The observation of a high correlation between microvessel counts and both total metachromatic and tryptase-reactive MC in <z:hpo ids='HP_0000001'>all</z:hpo> samples suggests that <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> increases with their progression and that MC may intervene in the angiogenic response in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> through tryptase contained in their secretory granules </plain></SENT>
</text></document>